John S. Welch

John S. Welch


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KKKedar Shirish Kirtane
Kedar Shirish Kirtane
MJMaie St. John
Maie St. John
HFHarry Fuentes-Bayne
Harry Fuentes-Bayne
SPSandip Pravin Patel
Sandip Pravin Patel
AMArmen Mardiros
Armen Mardiros
JWJohn S. Welch
John S. Welch
Head and neck squamous cell cancers (HNSCCs) represent a diverse group of tumors emerging within different mucosal surfaces of the oral cavity, nasopharynx, oropharynx, larynx, and hypopharynx. HNSCCs share common clinical risk factors and genomic features, including smoking, alcohol, age, male sex, aneuploidy, and TP53 mutations. Viral initiating and contributing events are increasingly recognized in HNSCCs. While both Epstein–Barr Virus (EBV) and human papilloma virus (HPV) are observed, EBV is more frequently associated with nasopharyngeal cancers whereas HPV is associated with oropharyngeal cancers. HNSCCs are associated with high tumor mutational burden and loss of tumor suppressor gene function, especially in TP53 and X-linked genes. Multiple lines of evidence suggest that HNSCCs are subject to immunologic surveillance and immune-induced evolutionary pressure that correlate with negative clinical outcomes. This review will discuss genomic mechanisms related to immune-mediated pressures and propose prognostic and therapeutic implications of detectable immune escape mechanisms that drive tumorigenesis and disease progression.

11 April 2024 in Haematologica
Verified
Journal Article
Open access
PDF file
AGAgata Gruszczynska
Agata Gruszczynska
AMAbhishek Maiti
Abhishek Maiti
CMChristopher A. Miller
Christopher A. Miller
SRSai Mukund Ramakrishnan
Sai Mukund Ramakrishnan
DLDaniel C. Link
Daniel C. Link
JWJohn S. Welch
John S. Welch
Molecular responses in decitabine-and decitabine